Prediction of Intravenous Immunoglobulin Unresponsiveness in Patients With Kawasaki Disease
Top Cited Papers
- 6 June 2006
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 113 (22) , 2606-2612
- https://doi.org/10.1161/circulationaha.105.592865
Abstract
Background— In the present study, we developed models to predict unresponsiveness to intravenous immunoglobulin (IVIG) in Kawasaki disease (KD). Methods and Results— We reviewed clinical records of 546 consecutive KD patients (development dataset) and 204 subsequent KD patients (validation dataset). All received IVIG for treatment of KD. IVIG nonresponders were defined by fever persisting beyond 24 hours or recrudescent fever associated with KD symptoms after an afebrile period. A 7-variable logistic model was constructed, including day of illness at initial treatment, age in months, percentage of white blood cells representing neutrophils, platelet count, and serum aspartate aminotransferase, sodium, and C-reactive protein, which generated an area under the receiver-operating-characteristics curve of 0.84 and 0.90 for the development and validation datasets, respectively. Using both datasets, the 7 variables were used to generate a simple scoring model that gave an area under the receiver-operating-characteristics curve of 0.85. For a cutoff of 0.15 or more in the logistic regression model and 4 points or more in the simple scoring model, sensitivity and specificity were 86% and 67% in the logistic model and 86% and 68% in the simple scoring model. The kappa statistic is 0.67, indicating good agreement between the logistic and simple scoring models. Conclusions— Our predictive models showed high sensitivity and specificity in identifying IVIG nonresponders among KD patients.Keywords
This publication has 33 references indexed in Scilit:
- Risk factors associated with the need for additional intravenous gamma-globulin therapy for Kawasaki diseaseActa Paediatrica, 2006
- Effect of Initial Corticosteroid Therapy on Coronary Artery Aneurysm Formation in Kawasaki Disease: A Meta-analysis of 862 ChildrenPediatrics, 2005
- Infliximab treatment for refractory Kawasaki syndromeThe Journal of Pediatrics, 2005
- Efficacy of intravenous immune globulin therapy combined with dexamethasone for the initial treatment of acute Kawasaki diseaseEuropean Journal of Pediatrics, 2004
- Early intravenous gamma-globulin treatment for kawasaki disease: The nationwide surveys in JapanThe Journal of Pediatrics, 2004
- CD8 T Lymphocytes and Macrophages Infiltrate Coronary Artery Aneurysms in Acute Kawasaki DiseaseThe Journal of Infectious Diseases, 2001
- Intravenous γ‐Globulin Treatment in Kawasaki DiseasePediatrics International, 1991
- Scoring method for identifying patients with Kawasaki disease at high risk of coronary artery aneurysmsThe American Journal of Cardiology, 1986
- The Treatment of Kawasaki Syndrome with Intravenous Gamma GlobulinNew England Journal of Medicine, 1986
- Evaluation Method for the degree of seriousness in Kawasaki DiseasePediatrics International, 1983